Chinese Journal of Antituberculosis ›› 2021, Vol. 43 ›› Issue (3): 217-221.doi: 10.3969/j.issn.1000-6621.2021.03.005
• Expert Note • Previous Articles Next Articles
CHENG Jun, ZHANG Can-you, CHEN Hui, ZHANG Hui, ZHAO Yan-lin()
Received:
2021-01-18
Online:
2021-03-10
Published:
2021-03-03
Contact:
ZHAO Yan-lin
E-mail:zhaoyl@chinacdc.cn
CHENG Jun, ZHANG Can-you, CHEN Hui, ZHANG Hui, ZHAO Yan-lin. Strengthen tuberculosis control strategy in key populations according to local conditions[J]. Chinese Journal of Antituberculosis, 2021, 43(3): 217-221. doi: 10.3969/j.issn.1000-6621.2021.03.005
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.zgflzz.cn/EN/10.3969/j.issn.1000-6621.2021.03.005
[1] |
Wang L, Zhang H, Ruan Y, et al. Tuberculosis prevalence in China, 1990—2010; a longitudinal analysis of national survey data. Lancet, 2014,383(9934):2057-2064. doi: 10.1016/S0140-6736(13)62639-2.
doi: 10.1016/S0140-6736(13)62639-2 URL pmid: 24650955 |
[2] | World Health Organization. Global tuberculosis report 2020. Geneva:World Health Organization, 2020. |
[3] |
Huynh GH, Klein DJ, Chin DP, et al. Tuberculosis control strategies to reach the 2035 global targets in China: the role of changing demographics and reactivation disease. BMC Med, 2015,13:88. doi: 10.1186/s12916-015-0341-4.
doi: 10.1186/s12916-015-0341-4 URL |
[4] | World Health Organization. Systematic Screening for Active Tuberculosis: Principles and Recommendations. Geneva:World Health Organization, 2013. |
[5] | 中华人民共和国国务院办公厅. 国务院办公厅关于印发全国结核病防治规划(2011—2015年)的通知. 国办发〔2011〕53号. 2011-12-06. |
[6] | 中华人民共和国国务院办公厅. 国务院办公厅关于印发“十三五”全国结核病防治规划的通知. 国办发〔2017〕16号. 2017-02-01. |
[7] | 中华人民共和国国家卫生健康委员会, 中华人民共和国国家发展改革委员会, 中华人民共和国教育部, 等. 遏制结核病行动计划(2019—2022年). 国卫疾控发〔2019〕41号. 2019-05-31. |
[8] | 中华人民共和国国家卫生健康委员会办公厅. 关于印发中国结核病预防控制工作技术规范(2020年版)的通知. 国卫办疾控函〔2020〕279号. 2020-04-02. |
[9] | 中华人民共和国国家卫生健康委员会. 关于印发中国学校结核病防控指南的通知. 国卫办疾控函〔2020〕910号. 2020-10-16. |
[10] | 王宇. 全国第五次结核病流行病学抽样调查资料汇编. 北京: 军事医学科学出版社, 2011: 24. |
[11] |
Cheng J, Wang L, Zhang H, et al. Diagnostic value of symptom screening for pulmonary tuberculosis in China. PLoS One, 2015,10(5):e0127725. doi: 10.1371/journal.pone.0127725.
doi: 10.1371/journal.pone.0127725 URL pmid: 26001190 |
[12] |
Lin Y, Li L, Mi F, et al. Screening patients with diabetes mellitus for tuberculosis in China. Trop Med Int Health, 2012,17(10):1302-1308. doi: 10.1111/j.1365-3156.2012.03069.x.
doi: 10.1111/j.1365-3156.2012.03069.x URL pmid: 22830951 |
[13] |
Lin Y, Innes A, Xu L, et al. Screening of patients with diabetes mellitus for tuberculosis in community health settings in China. Trop Med Int Health, 2015,20(8):1073-1080. doi: 10.1111/tmi.12519.
doi: 10.1111/tmi.12519 URL pmid: 25877338 |
[14] | World Health Organization. Latent tuberculosis infection. Updated and consolidated guidelines for programmatic management. Geneva:World Health Organization, 2018. |
[15] | 殷继国, 何卫华, 练祖银, 等. HIV/AIDS患者结核感染预防性治疗效果评价研究. 中国防痨杂志, 2010,32(12):791-794. |
[16] | 刘玉清, 屠德华, 安燕生, 等. 大学生结核病控制的研究:(二)结核感染者的预防性治疗. 中国防痨杂志, 2005,27(3):139-142. |
[17] | 刘雪洋, 支晨曦, 潘宏伟, 等. 某煤矿接尘工人下呼吸道疾病的患病现状调查. 中华劳动卫生职业病杂志, 2019,37(7):509-513. doi: 10.3760/cma.j.issn.1001-9391.2019.07.006. |
[18] | 黎东霞, 杨梅, 杨雅愉, 等. 17071名接尘工人职业健康检查结果分析. 工业卫生与职业病, 2017,43(4):276-279. doi: 10.13692/j.cnki.gywsyzyb.2017.04.010. |
[19] | 唐云霞, 曲亚斌, 李华, 等. 矽肺矿工肺结核患病情况及结核菌素反应的调查分析. 环境与职业医学, 2005,22(3):261-263. |
[20] |
Macedo Couto R, Ranzani OT, Waldman EA. Zoonotic Tuberculosis in Humans: Control, Surveillance, and the One Health Approach. Epidemiol Rev, 2019,41(1):130-144. doi: 10.1093/epirev/mxz002.
doi: 10.1093/epirev/mxz002 URL pmid: 32294188 |
[21] | World Health Organization. Global tuberculosis report 2017. Geneva:World Health Organization, 2017. |
[22] |
Gallivan M, Shah N, Flood J. Epidemiology of human Mycobacterium bovis disease, California, USA, 2003—2011. Emerg Infect Dis, 2015,21(3):435-443. doi: 10.3201/eid2103.141539.
doi: 10.3201/eid2103.141539 URL pmid: 25693687 |
[23] |
Davidson JA, Loutet MG, O’Connor C, et al. Epidemiology of Mycobacterium bovis disease in humans in England, Wales, and Northern Ireland, 2002—2014. Emerg Infect Dis, 2017,23(3):377-386. doi: 10.3201/eid2303.161408.
doi: 10.3201/eid2303.161408 URL pmid: 28220748 |
[24] |
Valle MB, Torres-González P, Cervera-Hernández ME, et al. Trends of Mycobacterium bovis isolation and first-line anti-tuberculosis drug susceptibility profile: a fifteen-year laboratory-based surveillance. PLoS Negl Trop Dis, 2015,9(9):e0004124. doi: 10.1371/journal.pntd.0004124.
doi: 10.1371/journal.pntd.0004124 URL pmid: 26421930 |
[25] |
Chen Y, Chao Y, Deng Q, et al. Potential challenges to the stop TB plan for humans in China; cattle maintain M.bovis and M.tuberculosis. Tuberculosis, 2009,89(1):95-100. doi: 10.1016/j.tube.2008.07.003.
doi: 10.1016/j.tube.2008.07.003 URL pmid: 19056318 |
[26] | 贾俊青, 岳建军, 孙晓燕, 等, 脊柱结核病灶分枝杆菌培养菌种鉴定及耐药分析. 中国药物与临床, 2012,12(增刊):22-24. |
[27] | 田玉莲, 徐英, 常海霞. 2009—2015年乌鲁木齐地区住院流浪精神病患者并发传染病流行病学分析. 实用预防医学, 2017,24(10):1237-1239. doi: 10.3969/j.issn.1006-3110.2017.10.025. |
[28] |
Thrupp L, Bradley S, Smith P, et al. Tuberculosis prevention and control in long-term-care facilities for older adults. Infect Control Hosp Epidemiol, 2004,25(12):1097-1108. doi: 10.1086/502350.
doi: 10.1086/502350 URL pmid: 15636299 |
[29] | 陈军华, 黄谷孙, 陈宏辉. 2008—2012 年日本结核病流行病学分析. 传染病信息, 2016,29(1):47-51. doi: 10.3969/j.issn.1007-8134.2016.01.009. |
[30] |
Gao L, Zhang H, Xin H, et al. Short-course regimens of rifapentine plus isoniazid to treat latent tuberculosis infection in older Chinese patients: a randomised controlled study. Eur Respir J, 2018,52(6):1801470. doi: 10.1183/13993003.01470-2018.
doi: 10.1183/13993003.01470-2018 URL pmid: 30361241 |
[1] | Tuberculosis Control Branch of Chinese Antituberculosis Association, The Youth Branch of Chinese Antituberculosis Association, Editorial Board of Chinese Journal of Antituberculosis. Evidence-based guidelines for application of digital adherence technology in tuberculosis medication management in China [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 385-397. |
[2] | Li Jinhao, Hu Dongmei, Xu Caihong. Investigation on the willingness of tuberculosis health-care workers to implement tuberculosis preventive treatment and analysis of influencing factors [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 398-407. |
[3] | Li Yuhong, Mei Jinzhou, Su Wei, Ruan Yunzhou, Liu Yushu, Zhao Yanlin, Liu Xiaoqiu. Analysis of the treatment outcomes and influencing factors of rifampicin-resistant pulmonary tuberculosis patients aged 65 and above in China from 2015 to 2021 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 408-415. |
[4] | Jiang Xue, Bai Yunlong, Ma Jianjun, An Yuan, Yang Fan, Zhao Qinglong. Status and influencing factors of diagnosis and treatment delay of rifampicin resistant pulmonary tuberculosis patients, Jilin Province, 2020—2023 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 416-424. |
[5] | Wu Xuan, Zhang Yanqiu, Xu Jiying, Meng Dan, Sun Dingyong. Analysis of factors influencing the treatment outcomes of patients with pulmonary tuberculosis and diabetes mellitus in Henan Province (2019—2023) [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 425-431. |
[6] | An Yuan, Bai Yunlong, Zhao Qinglong, Ma Jianjun, Jiang Xue, Pan Yan, Gao Ying, Gao Zhihui. Analysis of treatment outcomes and influencing factors of patients with pulmonary tuberculosis complicated with diabetes mellitus in Jilin Province,2018—2022 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 432-438. |
[7] | Feng Wei, Zheng Hailun, Meng Weili, Luo Ping. Analysis of under-reporting before arrival of pulmonary tuberculosis patients registered and managed by Tuberculosis Prevention and Control Institutions in Xicheng District, Beijing from 2018 to 2023 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 439-443. |
[8] | Hu Yifan, Du Boping, Wu Yadong, Zhu Chuanzhi, Zhang Lanyue, Jia Hongyan, Sun Qi, Pan Liping, Zhang Zongde, Li Zihui. Experimental study on the role of Mce4C in the uptake and utilization of cholesterol by Mycobacterium tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 444-453. |
[9] | Sheng Jie, Hong Kaifeng, Mierzhati Aisha, Tang Wei, Dilixiati Abulizi. Study on the mechanism of IL-22 and p38 MAPK signaling pathways in inhibiting bone destruction in bone and joint tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 454-459. |
[10] | Wang Yingchao, Liu Weiyi, Ji Xiuxiu, Shang Xuetian, Jia Hongyan, Zhang Lanyue, Sun Qi, Du Boping, Zhu Chuanzhi, Pan Liping, Zhang Zongde. Profile analysis of circRNA expression and identification of diagnostic markers in peripheral blood mononuclear cells of tuberculosis patients [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 460-470. |
[11] | Zhu Mingzhi, Shao Yanqin, Fan Dapeng, Liu Libin, Mei Bin, Dai Lingshan, Cai Long. Diagnostic value of urine lipoarabinomannan antigen detection in extrapulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 471-476. |
[12] | Hao Mingxiao, Mi Jie, Xu Zongyi. Effectiveness of a continuity of care model in patients with tuberculous meningitis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 477-481. |
[13] | Shang Xiyu, Zhang Huifang, Cao Yuqing, Xiong Yibai, Ji Xinyu, Tian Yaxin, Li Jiajia, Wang Ni, Ma Yan. Bibliometric analysis of global research status and hotspots in the basic research of Traditional Chinese Medicine for tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 482-497. |
[14] | Qin Lili, Yang Chengqing, Mai Hongzhen, Xu Qifeng, Xue Xinying, Lu Xiwei. Advances in the clinical diagnosis and treatment of post-tuberculosis chronic pulmonary aspergillosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 498-504. |
[15] | Luo Li, Luo Linzi, Yin Quhua, Zhou Lei, Lu Zhibin, Ding Yan, Xiao Yangbao. Progress in bronchoscopic diagnosis and treatment of lymph node fistula tracheobronchial tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 505-512. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||